Stock futures were higher following the lead of oil and gold, which were higher in overnight trading.
Here are some of the early market movers for Monday.
Compugen Ltd. (CGEN)
The company announced the discovery and experimental validation of CGEN-671, a new drug target for multiple epithelial tumors initially predicted in silico through the use of its Monoclonal Antibody Targets Discovery Platform. The news sent shares up 36.7% in pre-market trading.
Amicas Inc. (AMCS)
The healthcare IT services company announced it has agreed to be bought by the private equity firm Thoma Bravo LLC for $217 million in an all-cash deal. Amicas shares gained 21.5% in pre-market trading.
Vical Incorporated (VICL)
Shares jumped 20% in pre-market trading after the company announced that an independent Safety Monitoring Board for the trial of Allovectin-7(R) has completed the third scheduled safety analysis and recommended that the trial continue.
3PAR Inc. (PAR)
Shares of the data storage company gained 9.5% in pre-market trading after Barron’s said the company's strong data-security business could make it a takeover target for a big player.
Sinovac Biotech Ltd. (SVA)
The biopharmaceutical company announced its filing with China's State Food and Drug Administration to commence a human clinical trial for its vaccine against human enterovirus 71 which causes hand, foot, and mouth disease, the first such application in China. Shares were up 7.8% in pre-market trading.
AMR Corp. (AMR)
The parent company to American Airlines was down 9.8% in pre-market trading along with much of the sector amid heightened airline security and concern after the earlier alleged terrorist attempt to destroy a Northwest Airlines transatlantic flight.
Early-Market Movers: Questcor, Trimeris3Q income up for Dollar General
